<html><head><meta http-equiv="Content-Type" content="text/html charset=windows-1252"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;">Fellow developers,<div><br></div><div>Filmmaker and Pain Management Doctor & researcher Ben Daitz is working on a movie to educate doctors and patients about medical cannabis.</div><div><br></div><div> Part of the plan is an app to gather info from patients on what strains help with what malady at what doses so Doctors can learn to prescribe effectively.</div><div><br></div><div>If you are interested in helping, contact Ben at <a href="mailto:bdaitz@unm.edu">bdaitz@unm.edu</a></div><div><br></div><div><br><div><div><br><div>Begin forwarded message:</div><br class="Apple-interchange-newline"><blockquote type="cite"><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px;"><span style="font-family:'Helvetica'; color:rgba(0, 0, 0, 1.0);"><b>From: </b></span><span style="font-family:'Helvetica';">Benson Daitz <<a href="mailto:bdaitz@unm.edu">bdaitz@unm.edu</a>><br></span></div><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px;"><span style="font-family:'Helvetica'; color:rgba(0, 0, 0, 1.0);"><b>Subject: </b></span><span style="font-family:'Helvetica';"><b>Re: weed effectiveness app </b><br></span></div><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px;"><span style="font-family:'Helvetica'; color:rgba(0, 0, 0, 1.0);"><b>Date: </b></span><span style="font-family:'Helvetica';">July 31, 2017 at 7:56:59 PM MDT<br></span></div><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px;"><span style="font-family:'Helvetica'; color:rgba(0, 0, 0, 1.0);"><b>To: </b></span><span style="font-family:'Helvetica';">Andrew Stone <<a href="mailto:andrew@stone.com">andrew@stone.com</a>><br></span></div><br></blockquote><br><div><div style="margin: 0px; font-family: Times; font-size: 16px;"><b>DRAFT: A portable education and research interface linking patients, practitioners, and cannabis dispensaries. </b>(I’m tempted to call it Cannalinkus—but won’t)</div><div style="margin: 0px; font-family: Times; min-height: 14px; font-size: 16px;"><br></div><div style="margin: 0px; font-family: Times; font-size: 16px;">To date, there are an estimated 779 strains of cannabis in the world. In the 29 states where cannabis is legal to treat 20 or more medical conditions, patients are faced with an array of showy, sometimes gaudy names, variable delivery systems and dosages, and mostly anecdotal evidence of effectiveness. (a cann-a-worms) </div><div style="margin: 0px; font-family: Times; min-height: 14px; font-size: 16px;"><br></div><div style="margin: 0px; font-family: Times; font-size: 16px;">Medical practitioners may recommend, but by federal law cannot prescribe cannabis. In general, physicians know very little about it. Patients, at a once a year appointment, may only remember that “WD-40” or “Lemon Diesel” helps-- or not.</div><div style="margin: 0px; font-family: Times; min-height: 14px; font-size: 16px;"><br></div><div style="margin: 0px; font-family: Times; font-size: 16px;"> Researchers are stymied by DEA restrictions, and there are virtually no studies that definitively evaluate cannabis strains, pharmaceutical delivery modes, dosing schedules, and side effects--- what might be best for a particular medical condition. Instead, patients shop in dispensaries, and largely depend on anecdotal advice from “bud tenders,” the default experts.</div><div style="margin: 0px; font-family: Times; min-height: 14px; font-size: 16px;"><br></div><div style="margin: 0px; font-family: Times; font-size: 16px;">A portable, programmable, and privacy-secure app (HIPPA compatible) could better link patients, their medical providers, cannabis dispensers, and researchers, enabling each constituent group to track pertinent analytics in the evaluation of specific medical conditions and their response to different cannabis strains (cbd/thc ratios), delivery systems, and dosages. Side effects and compatibility with other medications could also be documented. Since clinical studies of cannabis are DEA- restricted, this app could also function, with HIPPA release, as a template for crowd-based research. </div></div><div style="font-size: 18px;"><br></div><div><br></div><br><blockquote type="cite"><div>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<div>
<div style="word-wrap:break-word"><br></div>
</div>
</div></blockquote></div></div></div></body></html>